T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers March 16, 2026 2 min The Medicine Maker Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Institutions